Skip to content

Clinical trials

Withdrawn Phase 2 Cognitive Dysfunction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 2 Status: Withdrawn Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20171
20212
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AC Immune SA1
AgeneBio1
Inmune Bio, Inc.1
Johns Hopkins University1
King's College London1
Massachusetts General Hospital1
Mayo Clinic1
Palo Alto Veterans Institute for Research1
Tammie L. S. Benzinger, MD, PhD1
Wake Forest University Health Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction10
Alzheimer Disease5
Brain Diseases2
Central Nervous System Diseases2
Dementia2
Neurodegenerative Diseases2
Tauopathies2
Brain Injuries1
Brain Injuries, Traumatic1
Combat Disorders1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.